Myanmar: Can't Protect Consumers From Harmful Imports (China)
This article was originally published in PharmAsia News
Executive Summary
Myanmar's government has said it cannot ensure all imported food and medicine is safe, amid growing international concerns about the safety of products from China. Myanmar is flooded with Chinese goods and traders say many are substandard if not harmful. But the poor nation's Food and Drug Administration (FDA) said it doesn't have enough resources to control the quality of all imported products. "The FDA currently has only 100 staff, which is not enough to carry out strict monitoring processes to ensure the safety of the 50 million people in Myanmar," says the agency's director, Dr. Kyaw Lin. However, the FDA's responsibilities will soon be expanded to include screening cosmetics, consumer goods and medical equipment. China is the fourth biggest supplier of legal pharmaceuticals to Myanmar behind India, Indonesia, and Bangladesh. Unregulated drugs also cross the border illegally. (Click here for more - May Require Paid Subscription
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.